Lucas Svetlana (CIK 1781292) reported 2 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-07-27). Recent activity: Buy SCTX (3,000 shares), Buy JSPR (20,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-27 | Scribe Therapeutics, Inc. (SCTX) | Chief Business Officer | Buy | 3,000 | $45,000 |
| 2025-09-24 | Jasper Therapeutics, Inc. (JSPR) | Director | Buy | 20,000 | $48,600 |
Source: SEC Form 4 filings · as of 2026-07-27